Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial. Watkins RR, Du B, Isaacs R, Altarac D, et al. Clin Infect Dis 2023;76.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Watkins RR, Du B, Isaacs R, Altarac D, et al. Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial. Clin Infect Dis 2023;76.
PMID: 37125468